Literature DB >> 6969559

Corticosteroids in acute myocardial infarction.

C A Bush, W Renner, H Boudoulas.   

Abstract

Forty-two patients admitted to the Coronary Care Unit with a diagnosis of acute myocardial infarction were studied within 24 hours of the onset of symptoms. In addition to therapy determined by the attending physician, there was a double-blinded administration of either a placebo or methylprednisolone, 30 mg/kg intravenously every 6 hours for four doses. This drug had no beneficial effect on infarct size, dysrhythmias, complications, or left ventricular function 2 weeks after infarction.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6969559     DOI: 10.1177/000331978003101007

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  3 in total

Review 1.  Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges.

Authors:  Shuaibo Huang; Nikolaos G Frangogiannis
Journal:  Br J Pharmacol       Date:  2018-03-04       Impact factor: 8.739

2.  Phosphatidylserine Supplementation as a Novel Strategy for Reducing Myocardial Infarct Size and Preventing Adverse Left Ventricular Remodeling.

Authors:  David Schumacher; Adelina Curaj; Mareike Staudt; Franziska Cordes; Andreea R Dumitraşcu; Benjamin Rolles; Christian Beckers; Josefin Soppert; Mihaela Rusu; Sakine Simsekyilmaz; Kinan Kneizeh; Chrishan J A Ramachandra; Derek J Hausenloy; Elisa A Liehn
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

3.  Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction.

Authors:  Michael Lichtenauer; Michael Mildner; Andrea Baumgartner; Matthias Hasun; Gregor Werba; Lucian Beer; Patrick Altmann; Georg Roth; Mariann Gyöngyösi; Bruno Karl Podesser; Hendrik Jan Ankersmit
Journal:  Basic Res Cardiol       Date:  2011-03-17       Impact factor: 17.165

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.